The SF-36 health survey as a generic outcome measure in clinical trials of patients with psteoarthritis and rheumatoid arthritis. Relative validity of scales in relation to clinical measures of arthritis severity

Medical Care

Volumn 37, Issue 5 SUPPL. 1, 1999, Pages

  Kosinski, Mark ^a   Keller, Susan D ^a   Ware Jr , John E ^a,e   Hatoum, Hind T ^b,c   Kong, Sheldon Xiaodong ^b,d  

^a TUFTS MEDICAL CENTER   (United States)

^b PFIZER INC   (United States)

^c Hind T Hatoum and Company   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e Health Institute   (United States)

Author keywords

Arthritis; Clinical trials; SF 36; Validity

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; MALE; MULTIVARIATE ANALYSIS; OSTEOARTHRITIS; OUTCOME ASSESSMENT; QUESTIONNAIRE; REPRODUCIBILITY; RHEUMATOID ARTHRITIS; STANDARD; STATISTICS; TIME;

ADULT; ANALYSIS OF VARIANCE; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MULTIVARIATE ANALYSIS; OSTEOARTHRITIS; OUTCOME ASSESSMENT (HEALTH CARE); QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 27844435182     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-199905001-00003     Document Type: Review

References (36)

1. Patrick DL, Erickson P. Health status and health policy: Allocating resources to health care. New York: Oxford University Press, 1993.
2. Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia: Lippincott-Raven, 1996.
3. Ware JE. The status of health assessment 1994. Annu Rev Public Health 1995;16:327.
4. Wright JG. Quality of life in orthopedics. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. 2nd Ed. Philadelphia: Lippincott-Raven, 1996:1039.
5. Beusterian KM, Nissenson AR, Port FK, et al. The effects of rHu erthropoietin on functional health and well-being in chronic dialysis patients. J Am Soc Nephrol 1996;7:1.
6. Noonan M, Chervinsky P, Busse WW, et al. Fluticasone propionate and aerosol reduces oral prednisone requirements while it improves control of asthma quality of life. Am J Respir Crit Care Med 1995;152:1467.
7. Evans RW, Rader B, Manninent DL. Cooperative Multicenter EPO Clinical Trial Group. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. JAMA 1990;263:825.
8. Bombardier C, Raboud J, The Auranofin Cooperating Group. A comparison of health-related quality-of-life measures for rheumatoid arthritis research. Controlled Clin Trials 1991;12:243S.
9. Croog SH, Levine S, Testa MA, et al. The effects of antihypertension therapy on the quality of life. N Engl J Med 1986;314:1657.
10. Brenner MH, Curbow B, Legro MW. The proximal-distal continuum in multiple health outcome measure: The case of cataract surgery. Med Care 1995;33(suppl 4):AS236.
11. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: A conceptual model of patient outcomes. JAMA 195;273:59.
12. McHorney CA, Kosinski M, Ware JE. Comparisons of the costs and quality of norms from the SF-36 Health Survey collected by mail versus telephone interview: Results from a national survey. Med Care 1994;32:551.
13. Weaver A, Rubin B, Caldwell J, et al. Comparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the knee. Clin Ther 1995;17:735.
14. Makarowski W, Weaver A, Rubin B, et al. The efficacy, tolerability, and safety of 1200 mg/d of oxaprozin and 1500 mg/d of nabumetone in the treatment of patients with osteoarthritis of the knee. Clin Ther 1996;18:1.
15. Kosinski M, Keller SD, Hatoum HT, Kong SX, Ware JE, Jr. The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: Tests of data quality, scaling assumptions and score reliability. The Health Institute, New England Medical Center. Med Care 1999;37(suppl):MS10.
16. Ware JE, Kosinski M, Bayliss MS, et al. Comparison of methods for the scoring and statistical analysis of the SF-36 Health Profile and Summary Measures: Summary results from the Medical Outcomes Study. Med Care 1995;33:AS264.
17. Ware JE, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: A user's manual. Boston, MA: The Health Institute, New England Medical Center, 1994.
18. Kerlinger FN. Foundations of behavioral research. 2nd ed. New York: Holt, Rinehart and Wilson, 1973.
19. Jacobs JWG, van der Heide A, Rasker JJ, et al. Measurement of functional ability and health status in the arthritic patient. Patient Educ Counsel 1993;20:121.
20. McHorney CA, Ware JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247.
21. Wagner AK, Keller SD, Kosinski M, et al. Advances in methods for assessing the impact of epilepsy and anti-epileptic drug therapy on patients' health-related quality of life. Qual Life Res 1995;4:115.
22. Liang MH, Larson MG, Cullen KE, et al. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 1985;28:542.
23. Krol K, Sandersman R, Suurmeijer T, et al. Medical, physical, and psychosocial status related to early rheumatoid arthritis. Clin Rheumatol 1995;14:143.
24. Sherrer YS, Block DA, Young DY, et al. The development of disability in rheumatoid arthritis. Arthritis Rheumatol 1986;29:494.
25. Mitchell DM, Spitz PW, Young DY, et al. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheumatol 1986:29:706.
26. de Bock GH, Kaptein AA, Touw-Otten F, et al. Health-related quality of life in patients with osteoarthritis in a family practice setting. Arthritis Care Res 1995;6:88.
27. Owen SG, Friesen WT, Roberts MS, et al. Functional capacity and treatment data from a community based study of patients with rheumatoid arthritis. Ann Rheum Dis 1986;45:293.
28. Yelin EH, Meenan RF, Nevitt M, et al. Work disability in rheumatoid arthritis: Effects of disease, social and work factors. Ann Intern Med 1980;93:551.
29. Pincus T, Mitchell JM, Burkhauser RV. Substantial work disability and earnings losses in individuals less than age 65 with osteoarthritis: Comparisons with rheumatoid arthritis. J Clin Epidemiol 1989;42:449.
30. Cassileth R, Lusk EJ, Strouse TB, et al. Psychosocial status in chronic illness. A comparative study of six diagnostic groups. N Engl J Med 1984;311:506.
31. Deyo RA, Inui TS, Leininger J, Overman S. Physical and psychosocial function in rheumatoid arthritis: Clinical use of a self-administered health status instrument. Arch Int Med 1982;142:879.
32. Fifield J, Reisine S. Characterizing the meaning of psychological distress in rheumatoid arthritis. Arthritis Care Res 1992;5:184.
33. Brown GK. A causal analysis of chronic pain and depression. J Abnorm Psychol 1990;99:127.
34. Bell MJ, Bombardier C, Tugwell P. Measurement of functional status, quality of life, and utility in rheumatoid arthritis. Arthritis Rheum 1990;33:591.
35. Karlson EW, Katz JN, Liange MH. Chronic rheumatic disorders. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. 2nd Ed. Philadelphia: Lippincott-Raven, 1996:1029.
36. Husted JA, Gladman DD, Farewell VT, et al. Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. J Rheumatol 1997;24:511.